OfficeLife sciencesLondonUK & Ireland
20 Dec 2021 | 08:00 GMT | by Stuart Clelland
Orchard Therapeutics develops and manufactures gene and cell therapies
Regal brings property management in-house
LaSalle star Zerda to leave
Private equity ramps up presence in London real estate
WPP offers free meals to lure staff back to office
Urban Logistics REIT confirms bid approach from LondonMetric
Scottish hotel group locks in £40m refinancing
Muse submits plans for £450m Oldham regeneration
Just 3% of fines collected from offshore property firms
Automotive sector to drive European sale and leasebacks
Greykite launches multi-let industrial platform with €1bn ambitions
Patrizia’s UK heads depart
Moda partners with private equity titan for £1bn+ student strategy
Real estate stocks tumble as tariff war escalates
UK law firm shortlists trio for 300,000 sq ft London HQ hunt
Former KKR UK head scores with Neville and Fora
Squarepoint agrees 400,000 sq ft London HQ prelet
US private equity firm preps £160m retail park portfolio sale
Nuveen weighs £550m Devonshire Square sale
Blackstone raises record €9.8bn European real estate fund
Two major housebuilders weigh return to London market
Company | Price (p) | % change |
![]() | 0.4768 GBP | -0.13% |
![]() | 3.524 GBP | 1.97% |
![]() | 18.02 GBP | 2.27% |
![]() | 2.835 GBP | 0.89% |
![]() | 2.342 GBP | 1.21% |
![]() | 5.33 GBP | 1.33% |
![]() | 1.821 GBP | 1.73% |
![]() | 0.9725 GBP | 2.05% |
![]() | 6.308 GBP | 0.90% |
![]() | 1.203 GBP | 1.52% |
![]() | 0.768 GBP | 0.79% |
![]() | 1.297 GBP | 0.46% |
![]() | 8.31 GBP | 0.97% |
![]() | 4 GBP | 1.27% |